General MedicationsORALStandard
OPIPZA
ARIPIPRAZOLE
Standard Dose
2MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview OPIPZA is listed in Drugs@FDA under application 216655 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ARIPIPRAZOLE Form and strength FILM;ORAL - 2MG Sponsor XIAMEN LP PHARM CO Submission history Latest submission status date: 2025-03-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview OPIPZA is listed in Drugs@FDA under application 216655 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ARIPIPRAZOLE Form and strength FILM;ORAL - 2MG Sponsor XIAMEN LP PHARM CO Submission history Latest submission status date: 2025-03-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.